Breaking News

Catalent, PAREXEL CTM Supply Chain Alliance

October 2, 2012

Aims to provide a fully integrated service offering for clinical trial materials

Catalent Pharma Solutions has entered a global alliance with PAREXEL to help streamline the clinical trial supply process. The alliance aims to provide a seamless, fully integrated service offering to ensure the timely and efficient delivery of clinical trial materials.
 
The alliance will provide the following services and technologies: planning and development of supply strategies, material supply and demand forecasting, central and local clinical trial and ancillary material sourcing, clinical manufacturing and packaging solutions, worldwide regulatory and import/export management, global and local storage as well as distribution to trial sites, depot, site and patient inventory management, material return and destruction/disposition.
 
“As clinical trials become more complex, we feel it is imperative to help sponsors devise supply strategies and organize consistent manufacturing, packaging, and delivery of trial-related supplies to locations around the world,” said Gerry Hepburn, chief operating officer, vice president and general manager of Clinical Supply Services at Catalent. “PAREXEL, with its extensive and unparalleled track record in clinical development, is the ideal partner for Catalent in this alliance, which will enable our customers to compete more effectively in the global marketplace.”
 
“One of the most important steps in creating a strong, efficient clinical trial material supply chain is selecting a partner with innovative clinical packaging solutions and established global operations to oversee and coordinate all aspects of each critical supply chain stage,” said Kurt Norris, corporate vice president, Clinical Logistics Services, PAREXEL. “In establishing this alliance with Catalent, we have chosen a partner that is uniquely positioned to help biopharmaceutical companies reach critical development milestones through more efficient delivery of clinical trial supplies.”

Related Contract Manufacturing:

Related Packaging:

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks

  • The Growing Realm of Real-World Data

    Kristin Brooks, Contract Pharma||November 8, 2016
    PPD's Evidera acquisition aims to help clients address the growing demand for evidence from regulators and payers

  • Mastering Immunotherapy Clinical Trials: Dosing and Response

    Mastering Immunotherapy Clinical Trials: Dosing and Response

    Kristin Brooks, Contract Pharma||August 1, 2016
    Andrew Zupnick of Novella Clinical provides insights into dosing and measuring response in immunotherapy clinical trials

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research